FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.
View Top Employees from FoRx TherapeuticsWebsite | https://www.forxtx.com |
Employees | 26 (20 on RocketReach) |
Founded | 2019 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Biotechnology Research, Drug Discovery, Biotechnology |
Looking for a particular FoRx Therapeutics employee's phone or email?
Ulrich Luecking is the Vice President, Head of Chemistry of FoRx Therapeutics.
20 people are employed at FoRx Therapeutics.